Last updated on April 2020

Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis

Brief description of study

This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.

Clinical Study Identifier: NCT03982394

Find a site near you

Start Over